|
|
|
201-500 employees
View all
|
|
Biotechnology
|
|
10578 Science Center Dr, Suite 125, San Diego, California 92121, US
|
|
Avidity Biosciences, Inc. | 3,050 followers on LinkedIn. At Avidity, we are developing a new class of oligonucleotide-based therapies. | At Avidity, we are developing a new class of oligonucleotide-based therapies. We utilize our proprietary AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. We hope that our AOC therapies can treat a wide range of serious diseases and our initial focus is on muscle diseases.
|
Avidity Biosciences, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Avidity Biosciences, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Avidity Biosciences, Inc. customer service number in your country click here to find.
Sarah Boyce is the CEO of Avidity Biosciences, Inc.. To contact Sarah Boyce email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.